Emerging and re-emerging viral diseases, predisposing risk factors, and implications of international travel: a call for action for increasing vigilance and imposing restrictions under the current threats of recently emerging multiple Omicron subvariants

doi:10.1097/JS9.0000000000000176

. 2023 Mar 1;109(3):589-591.

doi: 10.1097/JS9.0000000000000176.

Emerging and re-emerging viral diseases, predisposing risk factors, and implications of international travel: a call for action for increasing vigilance and imposing restrictions under the current threats of recently emerging multiple Omicron subvariants

Oroshay Kaiwan^{1

2}, Yashendra Sethi^{1

3}, Nimrat Khehra⁴, Inderbir Padda⁵, Hitesh Chopra⁶, Deepak Chandran⁷, Kuldeep Dhama⁸, Chiranjib Chakraborty⁹, Md Aminul Islam^{10

11}, Nirja Kaka^{1

12}

Affiliations

¹ PearResearch, Dehradun, Uttarakhand, India.
² Northeast Ohio Medical University, Ohio, USA.
³ Government Doon Medical College, HNB Uttarakhand Medical Education University, Dehradun, Uttarakhand, India.
⁴ Saint James School of Medicine, Arnos Vale, St Vincent & the Grenadines.
⁵ Richmond University Medical Center, Staten Island, New York.
⁶ Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
⁷ Department of Veterinary Sciences and Animal Husbandry, Amrita School of Agricultural Sciences, Amrita Vishwa, Vidyapeetham University, Coimbatore, Tamil Nadu.
⁸ Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal.
⁹ Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh.
¹⁰ COVID-19 Diagnostic Lab, Department of Microbiology, Noakhali Science and Technology University, Noakhali.
¹¹ Advanced Molecular Lab, Department of Microbiology, President Abdul Hamid Medical College, Karimganj, Kishoreganj, Bangladesh.
¹² GMERS Medical College, Himmatnagar, Gujarat, India.

PMID: 37093096
PMCID: PMC10389581
DOI: 10.1097/JS9.0000000000000176

Emerging and re-emerging viral diseases, predisposing risk factors, and implications of international travel: a call for action for increasing vigilance and imposing restrictions under the current threats of recently emerging multiple Omicron subvariants

Oroshay Kaiwan et al. Int J Surg. 2023.

. 2023 Mar 1;109(3):589-591.

doi: 10.1097/JS9.0000000000000176.

Authors

Affiliations

¹ PearResearch, Dehradun, Uttarakhand, India.
² Northeast Ohio Medical University, Ohio, USA.
³ Government Doon Medical College, HNB Uttarakhand Medical Education University, Dehradun, Uttarakhand, India.
⁴ Saint James School of Medicine, Arnos Vale, St Vincent & the Grenadines.
⁵ Richmond University Medical Center, Staten Island, New York.
⁶ Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
⁷ Department of Veterinary Sciences and Animal Husbandry, Amrita School of Agricultural Sciences, Amrita Vishwa, Vidyapeetham University, Coimbatore, Tamil Nadu.
⁸ Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal.
⁹ Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh.
¹⁰ COVID-19 Diagnostic Lab, Department of Microbiology, Noakhali Science and Technology University, Noakhali.
¹¹ Advanced Molecular Lab, Department of Microbiology, President Abdul Hamid Medical College, Karimganj, Kishoreganj, Bangladesh.
¹² GMERS Medical College, Himmatnagar, Gujarat, India.

PMID: 37093096
PMCID: PMC10389581
DOI: 10.1097/JS9.0000000000000176

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial conflict of interest with regard to the content of this report.

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Cited by

Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.
Leong RW, Sakiris A, Arzivian A, Chetwood JD, Chaemsupaphan T, Sparrow MP, Kamm MA, Kariayawasam V; Australian IBD Consensus Working Group. Leong RW, et al. Aliment Pharmacol Ther. 2025 Jan;61(1):132-144. doi: 10.1111/apt.18318. Epub 2024 Oct 10. Aliment Pharmacol Ther. 2025. PMID: 39387155 Free PMC article.
Dynamic modeling of mortality risk factors in Ebola virus disease using logistic regression on unbalanced panel data from a randomized controlled trial in the Democratic Republic of Congo.
Lawanga Ontshick L, Yango J, Mubiala Yaya A, Tshiani Mbaya O, Madinga Twan J, Nsengi Ntamabyaliro JM, Ali R, Lupola PM, Bukweli JD, Muchanga SM, Lutete GT, Kiangebeni PM, Mulangu S, Makengo Matendo RM. Lawanga Ontshick L, et al. PLOS Glob Public Health. 2025 Jul 11;5(7):e0004901. doi: 10.1371/journal.pgph.0004901. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40644455 Free PMC article.
Recent Advances on Targeting Proteases for Antiviral Development.
Borges PHO, Ferreira SB, Silva FP Jr. Borges PHO, et al. Viruses. 2024 Feb 27;16(3):366. doi: 10.3390/v16030366. Viruses. 2024. PMID: 38543732 Free PMC article. Review.

References

1. Dhama K, Nainu F, Frediansyah A, et al. . Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health 2023;16:4–14. - PMC - PubMed
1. Qu P, Evans JP, Faraone JN, et al. . Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe 2023;31:9–17.e3. - PMC - PubMed
1. Bolze A, Basler T, White S, et al. . Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination. Med (N Y). 2022;3:848–59.e4. - PMC - PubMed
1. Wong C. Subvariant ‘soup’ may drive wave. New Sci 2022;256:11. - PMC - PubMed
1. https://timesofindia.indiatimes.com/life-style/health-fitness/health-new... Coronavirus BF.7 variant symptoms | Coronavirus BF.7 variant dominant in China: Key points on transmission rate, symptoms, (n.d.). Accessed 26 December 2022.

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Dhama K, Nainu F, Frediansyah A, et al. . Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health 2023;16:4–14. - PMC - PubMed

[2] Dhama K, Nainu F, Frediansyah A, et al. . Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health 2023;16:4–14. - PMC - PubMed

[3] Qu P, Evans JP, Faraone JN, et al. . Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe 2023;31:9–17.e3. - PMC - PubMed

[4] Qu P, Evans JP, Faraone JN, et al. . Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe 2023;31:9–17.e3. - PMC - PubMed

[5] Bolze A, Basler T, White S, et al. . Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination. Med (N Y). 2022;3:848–59.e4. - PMC - PubMed

[6] Bolze A, Basler T, White S, et al. . Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination. Med (N Y). 2022;3:848–59.e4. - PMC - PubMed

[7] Wong C. Subvariant ‘soup’ may drive wave. New Sci 2022;256:11. - PMC - PubMed

[8] Wong C. Subvariant ‘soup’ may drive wave. New Sci 2022;256:11. - PMC - PubMed

[9] https://timesofindia.indiatimes.com/life-style/health-fitness/health-new... Coronavirus BF.7 variant symptoms | Coronavirus BF.7 variant dominant in China: Key points on transmission rate, symptoms, (n.d.). Accessed 26 December 2022.

[10] https://timesofindia.indiatimes.com/life-style/health-fitness/health-new... Coronavirus BF.7 variant symptoms | Coronavirus BF.7 variant dominant in China: Key points on transmission rate, symptoms, (n.d.). Accessed 26 December 2022.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Emerging and re-emerging viral diseases, predisposing risk factors, and implications of international travel: a call for action for increasing vigilance and imposing restrictions under the current threats of recently emerging multiple Omicron subvariants

Affiliations

Emerging and re-emerging viral diseases, predisposing risk factors, and implications of international travel: a call for action for increasing vigilance and imposing restrictions under the current threats of recently emerging multiple Omicron subvariants

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous